Drug
Infusions
Infusions: highest development phase Phase 3, developed by Polpharma. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Polpharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intravenous (IV) infusions NCT04115488 | Phase 3 | Relapsing-Remitting Multiple Sclerosis (RRMS) |
| Intravenous (IV) infusions NCT05771155 | Phase 3 | Ulcerative Colitis |
Latest
No recent events.
Follow Infusions on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.